Medical-Reference

Nothing can be more frightening for a person than having to undergo a serious medical procedure. Most are well aware that there is no guarantee of a successful outcome no matter what type of care is performed. There can be reasonable chances of procedure failures or unexpected accidents, but medical…

Description: Smog from motorized vehicles is one of the common environmental problems in large cities of Asia and Southeast Asia (Haze in Kuala Lumpur, Malaysia). Air pollution is a significant environmental determinant of human health. Over the past decades, studies conducted in various parts of th…

If you ask me to make a list of top five healthiest diets based on clinical study results, I can bet I will enlist the traditional Mediterranean diet as one of the top twos. Why? That's because it's simply a diet worth chasing. In fact, this is not just a diet to follow but a lifestyle choi…

Most physicians, if they had a choice, would rather clean up a soiled bedpan than spend any amount of their valuable time digging through medical codes to submit insurance claims for procedures they've performed or advised. Before getting their licenses, private practice doctors typically spen…

On 8th February 2012, the US-FDA issued a new warning on several popular proton pump inhibitors (PPI). The agency warned that the use of certain heartburn and acid reflux drugs might increase the risk of Clostridium difficile-associated diarrhea (CDAD. The agency also suggested considering a diagno…

In June 2011, Actos (Pioglitazone HCl), a leading diabetes medication globally, faced suspension in France and Germany over concerns of an increased bladder cancer risk. This action was prompted by a French epidemiological study's findings, revealing that long-term Actos users had a higher blad…

Actos (Pioglitazone), the most widely used diabetes medication in the world, is now facing multiple legal challenges due to the recent warning about the risk of developing bladder cancer with the drug. According to several recent reports, the litigation involving the type II diabetes medication is …